Speaker Profile

Ph.D., Vice-President of Engineering, Refractal

Biography
Steven Kaye leads product development and manufacturing of Refractal's home & point-of-care diagnostics. Prior to joining Refractal, Dr. Kaye led an advanced materials team in Apple's Special Projects Group. He also founded Mosaic Materials and was the Chief Scientific Officer at Wildcat Discovery Technologies, where he developed innovative materials and inventions for Fortune 100 clients across a range of industries including energy and vaccines. Dr. Kaye's work has led to over 60 patents and publications across a range of fields, including diagnostics, energy storage, and gas separations.


Health Monitoring Showcase:
Refractal

Refractal’s microfluidic platform automates sample collection/processing, enabling complex diagnostics to be performed at-home or point-of-care. Our first products include a saliva-based respiratory panel for COVID-19, flu, RSV, and strep & automated ELISA for blood biomarkers.

Automating Diagnostics for Home or Point-of-Care
Refractal’s microfluidic platform automates sample collection/processing, enabling complex diagnostics to be used at-home or point-of-care. I discuss the development and performance of Refractal’s first products: a saliva-based test for COVID-19, flu, RSV, and strep & automated ELISA for blood biomarkers.

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.